In the FCS there are nine high performance research groups, seven consolidated groups and four emerging ones. These are the groups, which you can consult here more details:

• BIOAESTHETICS (emerging)
• MOLECULAR DIABECANCER (high performance) 
• DIABEPOC (high performance)
• DIAGEPI (emerging)
• DOUBLE (high performance)
• GAMDES (popup)
• GIIECYC (high performance)
• HUM&QRINHS (consolidated)
• IDIBO (high performance)
• INVASC (consolidated)
• LAMBECOM (consolidated)
• LIPOBETA (high performance)
• NEUGUT (high performance)
• PHARMAKOM (high performance)
• PLURAL (consolidated)
• PSYCHOBALANCE (consolidated)
• RISAMA (consolidated)
• TMPSE (high performance)
• TO+IDI (consolidated)
• NEUROENDOCRINOLOGYAURJC (emerging)